1099852

David Gerber, M.D. — FEI 3015376662

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 19, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Dallas, TX (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
752021 CFR 312.64(b)Safety reports
756021 CFR 312.60FD-1572, protocol compliance